DARPA EQUIP-A-Pharma Revolutionizing Drug Manufaturing on Battlefield with Agile Platforms

The Defense Advanced Research Projects Agency (DARPA) is on a mission to revolutionize pharmaceutical manufacturing. Their EQUIP-A-Pharma program aims to develop a real-time approval framework for drugs produced using agile manufacturing platforms. The Defense Advanced Research Projects Agency (DARPA) launched in January 2024 , the EQUIP-A-Pharma program to address challenges in qualifying drug products manufactured…

IDST Monthly Access Membership Required

You must be a IDST Monthly Access member to access this content.

IDST Pro Access Required

This analysis is part of IDST premium intelligence.

Subscribe to Continue Reading